Amniotic Membrane Market | Need for Biocompatible Scaffolds to Boost the Market Growth | Technavio

LONDON--(BUSINESS WIRE)--The amniotic membrane market size is poised to grow by USD 1.48 billion during 2020-2024, progressing at a CAGR of over 13% throughout the forecast period, according to the latest report by Technavio. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. The report also provides the market impact and new opportunities created due to the COVID-19 pandemic. Download a Free Sample of REPORT with COVID-19 Crisis and Recovery Analysis.

The rising demand for biocompatible scaffolds will be a significant factor in driving the growth of the amniotic membrane market. Amniotic membranes have a specialized structure and exhibit high biological viability, including low immunogenicity, anti-inflammatory, anti-fibrosis, and reasonable mechanical properties. Moreover, the epithelial cells in amniotic membranes provide the advantages of stem cells and a native environment for cell seeding. These benefits, coupled with the growing demand for naturally derived materials in tissue scaffolding, have boosted the demand for amniotic membranes as biocompatible scaffolds in tissue engineering-based research and treatment procedures. These factors will boost the market growth.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Report Highlights:

• The major amniotic membrane market growth came from the cryopreserved amniotic membrane segment. Cryopreserved membranes are widely used in anti-inflammatory therapies, ocular surface repair, wound healing, protective coverings, and regenerative procedures. The increasing coverage of cryopreserved products in reimbursement schemes of governments and rising capital funding in tissue banks are some of the significant factors fueling the demand for cryopreserved amniotic membranes.
• North America was the largest market for amniotic membrane in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. Rising adoption of advanced wound care treatment and the increasing demand for orthopedic treatments are some of the significant factors contributing to amniotic membrane market growth in this region.
• The global amniotic membrane market is fragmented. Celularity Inc., Human Regenerative Technologies LLC, Integra LifeSciences Holdings Corp., Katena Products Inc., MiMedx Group Inc., NuVision Biotherapies Ltd., Orthofix Medical Inc., Stryker Corp., Surgenex LLC, and TissueTech Inc. are some of the major market participants. To help clients improve their market position, this amniotic membrane market forecast report provides a detailed analysis of the market leaders.
• As the business impact of COVID-19 spreads, the amniotic membrane market 2020-2024 is expected to have Positive and Superior growth. As the pandemic spreads in some regions and plateaus in other regions, we revaluate the impact on businesses and update our report forecasts.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Rise in the Development of New Applications Through Research will be a Key Market Trend

Considerable government funding and research activities have expanded the potential applications of amniotic membranes. Pipeline research on the development of amniotic membrane-based chitosan gel dressing for wound healing and effective wound management is underway. Advances in tissue preservation have enabled the development of amniotic membranes with new preservation technologies such as viable lyopreserved human amniotic membrane (VLAM). Research on the use of amniotic membranes in tissue remodeling, anti-cancer therapy, and lower nasal reconstruction is also being carried out. The research on the development of new applications will act as one of the critical amniotic membrane market trends that will have a positive impact on the growth of the market.

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

Amniotic Membrane Market 2020-2024: Key Highlights

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will assist amniotic membrane market growth during the next five years
• Estimation of the amniotic membrane market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the amniotic membrane market
• Analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of amniotic membrane market vendors

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

• Preface
• Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market Outlook

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: MARKET SEGMENTATION BY TYPE

• Market segmentation by type
• Comparison by type
• Cryopreserved amniotic membrane - Market size and forecast 2019-2024
• Dehydrated amniotic membrane - Market size and forecast 2019-2024
• Market opportunity by type

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• Asia - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 11: MARKET TRENDS

• Growing reimbursement coverage for new products
• Rise in development of new applications through research
• Industry consolidation through mergers and acquisitions

PART 12: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive scenario

PART 13: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Celularity Inc.
• Human Regenerative Technologies LLC
• Integra LifeSciences Holdings Corp.
• Katena Products, Inc.
• MiMedx Group Inc.
• NuVision Biotherapies Ltd.
• Orthofix Medical Inc.
• Stryker Corp.
• Surgenex LLC
• TissueTech Inc.

PART 14: APPENDIX

• Research methodology
• List of abbreviations
• Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.